Oudard, S., Culine, S., Vano, Y., Goldwasser, F., Théodore, C., Nguyen, T., Voog, E., Banu, E., Vieillefond, A., Priou, F., Deplanque, G., Gravis, G., Ravaud, A., Vannetzel, J. M., Machiels, J., Muracciole, X., Pichon, M., Bay, J., Elaidi, R., Teghom, C., Radvanyi, F., & Beuzeboc, P. (n.d.). multicentre randomised phase II trial of gemcitabine + platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2. European journal of cancer, 51(1), 45–54. http://access.bl.uk/ark:/81055/vdc_100025858848.0x000039